ro-journal.biomedcentral.com.preview-live.oscarjournals.springer.com
Current state of the art of regional hyperthermia treatment planning: a review | Radiation Oncology | Full Text
http://ro-journal.biomedcentral.com.preview-live.oscarjournals.springer.com/articles/10.1186/s13014-015-0503-8
Skip to main content. Search BioMed Central articles. We'd like your opinion about BioMed Central, help us by answering 3 questions. Current state of the art of regional hyperthermia treatment planning: a review. Kok et al. 2015. Examples of tumor sites for which adding hyperthermia proved effective are cervical cancer [ 2. Malignant melanoma [ 3. Recurrent breast cancer [ 4. Soft tissue sarcoma [ 5. And bladder cancer [ 6. Clinical outcome could improve further if power limiting hot spots are prevented&...
bmccancer.biomedcentral.com.preview-live.oscarjournals.springer.com
Li-Fraumeni syndrome with simultaneous osteosarcoma and liver cancer: Increased expression of a CD44 variant isoform after chemotherapy | BMC Cancer | Full Text
http://bmccancer.biomedcentral.com.preview-live.oscarjournals.springer.com/articles/10.1186/1471-2407-12-444
Skip to main content. Search BioMed Central articles. This article has Open Peer Review reports available. How does Open Peer Review work? Li-Fraumeni syndrome with simultaneous osteosarcoma and liver cancer: Increased expression of a CD44 variant isoform after chemotherapy. Yoshida et al. licensee BioMed Central Ltd. 2012. Open Peer Review reports. Li-Fraumeni syndrome (LFS) is a hereditary cancer predisposition syndrome that is commonly associated with a germline mutation in the tumor suppressor gene.
jitc.biomedcentral.com.preview-live.oscarjournals.springer.com
Journal for ImmunoTherapy of Cancer | Clinical/Translational Cancer Immunotherapy
http://jitc.biomedcentral.com.preview-live.oscarjournals.springer.com/articles/sections/clinical-translational-cancer-immunotherapy
Skip to main content. Search BioMed Central articles. Journal for ImmunoTherapy of Cancer. We'd like your opinion about BioMed Central, help us by answering 3 questions. Guidelines and Consensus Statements. Section edited by F. Stephen Hodi, Jr., MD. First-in-man clinical trials, phase II/III clinical studies, immune monitoring investigations, tumor microenvironment, host genetics and clinical outcome, combination therapies, and cell therapies. Page 1 of 3. Journal for ImmunoTherapy of Cancer. Journal fo...
jitc.biomedcentral.com.preview-live.oscarjournals.springer.com
Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironment | Journal for ImmunoTherapy of Cancer | Full Text
http://jitc.biomedcentral.com.preview-live.oscarjournals.springer.com/articles/10.1186/2051-1426-2-3
Skip to main content. Search BioMed Central articles. Journal for ImmunoTherapy of Cancer. Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8. T cells directly within the tumor microenvironment. Journal for ImmunoTherapy of Cancer. Spranger et al. licensee BioMed Central Ltd. 2014. Our data suggest that the therapeutic effect of these immunotherapies was mainly mediated through direct reactivation of T cells in situ...
ro-journal.biomedcentral.com.preview-live.oscarjournals.springer.com
Wound healing after radiation therapy: Review of the literature | Radiation Oncology | Full Text
http://ro-journal.biomedcentral.com.preview-live.oscarjournals.springer.com/articles/10.1186/1748-717X-7-162
Skip to main content. Search BioMed Central articles. Wound healing after radiation therapy: Review of the literature. Haubner et al. licensee BioMed Central Ltd. 2012. Radiation is employed as neoadjuvant, primary and adjuvant therapy for head and neck cancer. Complications after radiation therapy occur in up to 60 percent of surgical patients. Clinical sequelae include skin atrophy, soft tissue fibrosis, desquamation, epithelial ulceration, fistula formation and major vessel rupture[ 1. Hemostasis and ...
ro-journal.biomedcentral.com.preview-live.oscarjournals.springer.com
External beam radiotherapy for unresectable hepatocellular carcinoma, an international multicenter phase I trial, SAKK 77/07 and SASL 26 | Radiation Oncology | Full Text
http://ro-journal.biomedcentral.com.preview-live.oscarjournals.springer.com/articles/10.1186/s13014-016-0745-0
Skip to main content. Search BioMed Central articles. External beam radiotherapy for unresectable hepatocellular carcinoma, an international multicenter phase I trial, SAKK 77/07 and SASL 26. View ORCID ID profile. Daniel M. Aebersold. For the Swiss Group for Clinical Cancer Research (SAKK). The Author(s). 2017. To assess feasibility and safety of conventionally fractionated radiotherapy (cfRT) in patients with hepatocellular carcinoma (HCC). ClinicalTrials.gov identifier NCT00777894. Hepatocellular carc...
ro-journal.biomedcentral.com.preview-live.oscarjournals.springer.com
Long-term survival in patients with non-small cell lung cancer and synchronous brain metastasis treated with whole-brain radiotherapy and thoracic chemoradiation | Radiation Oncology | Full Text
http://ro-journal.biomedcentral.com.preview-live.oscarjournals.springer.com/articles/10.1186/1748-717X-6-166
Skip to main content. Search BioMed Central articles. Long-term survival in patients with non-small cell lung cancer and synchronous brain metastasis treated with whole-brain radiotherapy and thoracic chemoradiation. María D de la Mata. Jaime de la Garza. Arrieta et al; licensee BioMed Central Ltd. 2011. Median Progression-free survival (PFS) and Overall survival (OS) were 8.43 1.5 and 31.8 15.8 months, respectively. PFS was 39.5% at 1 year and 24.7% at 2 years. The 1- and...Patients with NSCLC and brain...
bmccancer.biomedcentral.com.preview-live.oscarjournals.springer.com
Prognostic significance of TRAIL-R3 and CCR-2 expression in tumor epithelial cells of patients with early breast cancer | BMC Cancer | Full Text
http://bmccancer.biomedcentral.com.preview-live.oscarjournals.springer.com/articles/10.1186/s12885-017-3259-8
Skip to main content. Search BioMed Central articles. This article has Open Peer Review reports available. How does Open Peer Review work? Prognostic significance of TRAIL-R3 and CCR-2 expression in tumor epithelial cells of patients with early breast cancer. María de Luján Calcagno. Scott C. Howard. The Author(s). 2017. Open Peer Review reports. High levels of TRAIL-R3 and CCR-2 expression in TEpCs identified patients with early breast cancer with poor outcomes. And in Argentina affects more than 25,000...
SOCIAL ENGAGEMENT